Published in Cell Host Microbe on June 14, 2017
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr (2011) 39.32
Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins (2003) 32.38
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem (2000) 19.03
Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A (1999) 14.90
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol (1997) 11.14
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature (1988) 8.32
Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature (1983) 8.28
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science (2004) 7.74
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A (2004) 7.18
Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet (2008) 6.79
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A (2001) 5.92
A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 5.66
Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology (1997) 4.96
Perspective: Sign epistasis and genetic constraint on evolutionary trajectories. Evolution (2005) 4.93
A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol (2005) 4.71
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus. J Virol (2000) 3.54
Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science (2012) 3.53
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Evolution of the receptor binding phenotype of influenza A (H5) viruses. Virology (2005) 3.32
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Aromatic rings act as hydrogen bond acceptors. J Mol Biol (1988) 2.77
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet (2016) 2.48
Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 2.44
Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science (2013) 2.34
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 2.29
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci U S A (2012) 2.18
Deep mutational scanning: a new style of protein science. Nat Methods (2014) 2.05
Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957. PLoS One (2010) 1.95
Studies of the binding properties of influenza hemagglutinin receptor-site mutants. Virology (1998) 1.95
Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol (2010) 1.83
Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic. J Virol (2012) 1.76
Sequence space and the ongoing expansion of the protein universe. Nature (2010) 1.72
Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog (2010) 1.69
Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J Virol (2011) 1.62
Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J Virol (2009) 1.50
The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol (2011) 1.48
Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science (2013) 1.37
Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS One (2009) 1.33
Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc Natl Acad Sci U S A (2012) 1.22
An experimentally determined evolutionary model dramatically improves phylogenetic fit. Mol Biol Evol (2014) 1.19
A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain. Curr Biol (2014) 1.19
The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin. Elife (2014) 1.18
Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses. Nat Rev Microbiol (2014) 1.10
Influenza H1N1 A/Solomon Island/3/06 virus receptor binding specificity correlates with virus pathogenicity, antigenicity, and immunogenicity in ferrets. J Virol (2010) 1.08
Development of high-yield influenza A virus vaccine viruses. Nat Commun (2015) 1.08
High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution. Sci Rep (2014) 1.03
Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies. Curr Top Microbiol Immunol (2015) 1.02
Analysis of influenza virus hemagglutinin receptor binding mutants with limited receptor recognition properties and conditional replication characteristics. J Virol (2011) 1.01
Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine (2010) 0.99
Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins. Virology (2015) 0.96
Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology (2011) 0.95
Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin. Viruses (2016) 0.89
Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules. J Virol (2011) 0.88
Functional Constraint Profiling of a Viral Protein Reveals Discordance of Evolutionary Conservation and Functionality. PLoS Genet (2015) 0.85
Adaptation of avian influenza A (H6N1) virus from avian to human receptor-binding preference. EMBO J (2015) 0.82
Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity. Cell Host Microbe (2016) 0.81
Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments. Vaccine (2013) 0.80
Structural Basis for a Switch in Receptor Binding Specificity of Two H5N1 Hemagglutinin Mutants. Cell Rep (2015) 0.80
A benchmark study on error-correction by read-pairing and tag-clustering in amplicon-based deep sequencing. BMC Genomics (2016) 0.77
Knotty Zika Virus Blocks Exonuclease to Produce Subgenomic Flaviviral RNAs. Cell Host Microbe (2017) 0.76
Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer. J Virol (2015) 0.75
Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526. J Mol Biol (2015) 0.78
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure. Immunity (2017) 0.78
Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin. Bioorg Med Chem Lett (2017) 0.75
A perspective on the structural and functional constraints for immune evasion: Insights from the influenza virus. J Mol Biol (2017) 0.75
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science (2020) 0.75